Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
TGF-BETA 2 AND NOVEL COMPOSITION HAVING ANTI-NEOPLASTIC ACTIVITY
Document Type and Number:
Japanese Patent JPS6434281
Kind Code:
A
Abstract:

PURPOSE: To inhibit the production of tumor cells without giving serious side effects to a host organism by bringing neoplastic cells into contact with a peptide comprising a specific amino acid sequence included in a perfect sequence.

CONSTITUTION: This method for inhibiting the proliferation of neoplastic cells comprises bringing the cells into contact with a polypeptide of the formula comprising the sequence of at least eight amino acids included in a perfect sequence. The peptide group known as a transformation growth factor type β(TGF-β) controls the growth and differentiation of the cells. The growth- controlling polypeptides can stimulate and inhibit the proliferation of (TGF-β1 and TGF-β2) cells mainly on the basis of the types of the cells. The transformation growth factor called as the TGF-β2 is available from the tomoxetine- supplemented culture medium of human prostatic cancer cells or human lung cancer cells.


Inventors:
HANSU MAAKAATO
IKEDA TAKEHIKO
MARIO ENU RIOOBIN
Application Number:
JP10773488A
Publication Date:
February 03, 1989
Filing Date:
May 02, 1988
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
ONCOGEN
International Classes:
A61K38/00; A61K39/395; A61P35/00; C07H21/04; C12N1/38; C12N5/00; C12N5/10; C12N15/00; C12N15/02; C12N15/09; C12P21/00; C12P21/02; C12P21/08; C12R1/91; (IPC1-7): A61K37/02; A61K39/395; C07H21/04; C12N1/38; C12N5/00; C12N15/00; C12P21/00; C12P21/02; C12R1/91
Domestic Patent References:
JP1501361Y
Attorney, Agent or Firm:
Takehiko Saito (1 outside)